PLC/PRF/5（人肝癌亚力山大细胞）

STAMBPL1, transcriptionally regulated by SREBP1, promotes malignant behaviors of hepatocellular carcinoma cells via Wnt/β-catenin signaling pathway(2024)

作者：Junyi Jin, Yihui Wang, Yaoyuan Hu

期刊：MOLECULAR CARCINOGENESIS

DOI：10.1002/mc.23801

影响因子：3.0

引用产品： PLC/PRF/5 细胞, Hep 3B2.1-7 细胞

The diagnostic, prognostic, drug sensitivity and ceRNA internet of PPP4R1 in liver hepatocellular carcinoma (LIHC)(2024)

作者：Xiaowei Li, Yinglian Pan, Siren Feng, Weimei Xing, Bo Lin, Wei Li, Mengsen Li, Mingyue Zhu

期刊：Translational Cancer Research

DOI：10.21037/tcr-23-1744

影响因子：0.9

引用产品： LX-2 细胞, HLE 细胞, HuH-7 细胞, PLC/PRF/5 细胞, Hep G2 细胞, 特级胎牛血清

Targeting USP8 Inhibits O-GlcNAcylation of SLC7A11 to Promote Ferroptosis of Hepatocellular Carcinoma via Stabilization of OGT(2023)

作者：Jianing Tang, Guo Long, Kuan Hu, Desheng Xiao, Shuang Liu, Liang Xiao, Ledu Zhou, Yongguang Tao

期刊：Advanced Science

DOI：10.1002/advs.202302953

影响因子：15.1

引用产品： HCCLM3 细胞, Hep G2 细胞, HuH-7 细胞, BEL-7404 细胞, Hep 3B2.1-7 细胞, PLC/PRF/5 细胞, 293T [HEK-293T] 细胞

Conjugating 4β-NH-(5-Aminoindazole)-podophyllotoxin and Galectin-1-Targeted Aptamer for Synergistic Chemo-Immunotherapy of Hepatocellular Carcinoma(2023)

作者：Ying Cong, Shu-Yue Zhang, Paula Yun-Zhi Tang, Hong-Mei Li, Xue Liu, Wei Zhao, Ya-Jie Tang

期刊：Advanced Healthcare Materials

DOI：10.1002/adhm.202203144

影响因子：10.0

引用产品： Hep G2 细胞, HuH-7 细胞, PLC/PRF/5 细胞, SNU387 细胞, MCF7 [MCF-7] 细胞, Hepa 1-6 细胞

Targeting DDX11 promotes PARP inhibitor sensitivity in hepatocellular carcinoma by attenuating BRCA2-RAD51 mediated homologous recombination(2023)

作者：Cao Kun, Wang Ruonan, Li Lianhai, Liao Yuting, Hu Xiao, Li Ruixue, Liu Xiuwen, Xiong Xing-dong, Wang Yanjie, Liu Xinguang

期刊：ONCOGENE

DOI：10.1038/s41388-023-02898-x

影响因子：8.0

引用产品： MHCC97-L 细胞, Hep G2 细胞, Hep 3B2.1-7 细胞, PLC/PRF/5 细胞, HuH-7 细胞

Targeting NAD+ metabolism of hepatocellular carcinoma cells by lenvatinib promotes M2 macrophages reverse polarization, suppressing the HCC progression(2023)

作者：Sun Qingcan, Shen Mengying, Zhu Subin, Liao Yanxia, Zhang Dongyan, Sun Jingyuan, Guo Zeqin, Wu Leyuan, Xiao Lushan, Liu Li

期刊：Hepatology International

DOI：10.1007/s12072-023-10544-7

影响因子：6.6

引用产品： Li-7 细胞, PLC/PRF/5 细胞, SNU-182 细胞, SNU-387 细胞, RAW 264.7 细胞

Silencing of keratin 15 impairs viability and mobility while facilitating the doxorubicin chemosensitivity by inactivating the β?catenin pathway in liver cancer(2023)

作者：Junying Wang, Guangyu Zhu

期刊：Oncology Letters

DOI：10.3892/ol.2023.14034

影响因子：2.9

引用产品： HuH-7 细胞, PLC/PRF/5 细胞, Hep 3B2.1-7 细胞, Hep G2 细胞, Li-7 细胞, RPMI-1640 培养基, DMEM高糖 培养基, 青霉素-链霉素溶液 (双抗)，100×

VEZF1, destabilized by STUB1, affects cellular growth and metastasis of hepatocellular carcinoma by transcriptionally regulating PAQR4(2022)

作者：Shi Xiaobao, Zhao Pengfei, Zhao Gang

期刊：CANCER GENE THERAPY

DOI：10.1038/s41417-022-00540-8

影响因子：5.9

引用产品： SK-Hep-1 细胞, PLC/PRF/5 细胞, HuH-7 细胞, Hep 3B2.1-7 细胞

SLC39A10 Upregulation Predicts Poor Prognosis, Promotes Proliferation and Migration, and Correlates with Immune Infiltration in Hepatocellular Carcinoma(2022)

作者：Zuyi Ma, Zhenchong Li, Shujie Wang, Qi Zhou, Zuguang Ma, Chunsheng Liu, Bowen Huang, Zehao Zheng, LinLing Yang, Yiping Zou, Chuanzhao Zhang, Shanzhou Huang, Baohua Hou

期刊：Journal of Hepatocellular Carcinoma

DOI：10.2147/JHC.S320326

影响因子：5.0

引用产品： MHCC97-L 细胞, HCCLM3 细胞, Hep G2 细胞, HL-7702 [L-02; LO2] 细胞, PLC/PRF/5 细胞, HuH-7 细胞, Hep 3B2.1-7 细胞

LncRNA AC026401.3 interacts with OCT1 to intensify sorafenib and lenvatinib resistance by activating E2F2 signaling in hepatocellular carcinoma(2022)

作者：Yun Wang, Kai Tan, Wen Hu, Yan Hou, Guang Yang

期刊：EXPERIMENTAL CELL RESEARCH

DOI：10.1016/j.yexcr.2022.113335

影响因子：4.1

引用产品： Hep 3B2.1-7 细胞, Hep G2 细胞, HuH-7 细胞, MHCC97-L 细胞, PLC/PRF/5 细胞, MIHA 细胞